Institutional Ownership Inozyme Pharma, Inc. (INZY)
This table provides information about the institutional ownership of Inozyme Pharma, Inc. (INZY). We have compiled data on the 4 institutions that hold shares in the stock, with a total of 4.86 Million shares, which have been reported (via 13F filing form) to have a value of $19.5 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,343,193
shares
|
$13.4 Million
0.0% of portfolio
|
Q2 2024
Added 8.24%
|
|
|
Chi Advisors LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
1,270,027
shares
|
$5.08 Million
2.63% of portfolio
|
Q3 2023
Added 6.28%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
250,229
shares
|
$1 Million
0.0% of portfolio
|
Q4 2024
Added 23.43%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|